The CAV3 gene limb-girdle muscular dystrophy autosomal dominant type 1C genetic test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the CAV3 gene, which are associated with limb-girdle muscular dystrophy type 1C (LGMD1C). LGMD1C is a rare form of muscular dystrophy that affects the voluntary muscles around the hips and shoulders (the limb-girdle muscles). This condition is characterized by progressive muscle weakness and wasting, typically beginning in late childhood or adulthood. The test involves analyzing the patient's DNA to detect any genetic alterations in the CAV3 gene that might lead to the development of LGMD1C. This information is crucial for confirming a diagnosis, understanding the prognosis, and making informed decisions about management and treatment options. The cost of the test at DNA Labs UAE is 4400 AED, offering a reliable resource for individuals and families seeking genetic insights into this condition.
The DNAJB6 gene plays a significant role in the development of limb-girdle muscular dystrophy, particularly the autosomal dominant type 1E (LGMD1E). This form of muscular dystrophy is characterized by progressive weakness and wasting of the limb-girdle muscles, which include the hips and shoulders. Mutations in the DNAJB6 gene disrupt its normal function, leading to the symptoms associated with LGMD1E.
To diagnose this specific type of muscular dystrophy, genetic testing is available at DNA Labs UAE. The test specifically looks for mutations in the DNAJB6 gene that are known to cause limb-girdle muscular dystrophy. This genetic test is crucial for accurate diagnosis, allowing for appropriate management and counseling for affected individuals and their families.
The cost of the DNAJB6 Gene Limb-girdle muscular dystrophy autosomal dominant type 1E Genetic Test at DNA Labs UAE is 4400 AED. The test is performed using a sample of the patient's blood, and the process involves analyzing the DNA to identify any mutations in the DNAJB6 gene. Results from this test can provide a definitive diagnosis, which is essential for understanding the prognosis and exploring potential treatment options.
The SGCD gene is associated with a specific form of muscular dystrophy known as limb-girdle muscular dystrophy type 2F (LGMD2F). This condition is characterized by progressive weakness and wasting of the limb muscles, particularly those around the hips and shoulders, making it part of the broader group of muscular dystrophies affecting the limb-girdle area. It is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected by the condition.
A genetic test for LGMD2F focuses on identifying mutations in the SGCD gene that are responsible for the condition. This test is crucial for confirming the diagnosis, understanding the progression of the disease, and making informed decisions about management and treatment options. It can also provide valuable information for family planning purposes.
In the United Arab Emirates, DNA Labs UAE offers this specific genetic test. The cost of the test is 4400 AED. DNA Labs UAE is equipped with state-of-the-art technology to ensure accurate and reliable results. By opting for this test at DNA Labs UAE, individuals suspected of having LGMD2F or families with a history of the condition can gain a deeper understanding of their genetic status and take proactive steps towards managing the disease effectively.
The NDUFS8 gene Leigh syndrome genetic test is a specialized diagnostic tool available at DNA Labs UAE, designed to detect mutations in the NDUFS8 gene that are associated with Leigh syndrome, a severe neurological disorder. This genetic condition typically manifests in infancy or early childhood and can lead to progressive loss of mental and movement abilities, ultimately resulting in serious health complications. The test is particularly crucial for early detection and management of the syndrome, offering families and healthcare providers vital information for planning treatment and care strategies. Priced at 4400 AED, the test involves analyzing the patient's DNA to identify any genetic alterations in the NDUFS8 gene, providing a clear diagnosis and helping to guide potential therapeutic interventions. DNA Labs UAE employs advanced genetic testing technologies to ensure accurate and reliable results, supporting patients and their families in navigating the complexities of genetic disorders like Leigh syndrome.
The NUBPL Gene Leigh Syndrome Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to detect mutations in the NUBPL gene, which are associated with Leigh syndrome. Leigh syndrome is a severe neurological disorder that typically arises in the first year of life, characterized by progressive loss of mental and movement abilities. The condition can lead to serious health complications, including respiratory failure and lactic acidosis, making early and accurate diagnosis crucial for managing symptoms and improving quality of life.
The test involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed to identify any genetic abnormalities in the NUBPL gene. This gene plays a critical role in the mitochondrial respiratory chain, which is essential for energy production in cells. Mutations in this gene can disrupt normal cellular function and lead to the symptoms observed in Leigh syndrome.
Priced at 4400 AED, the NUBPL Gene Leigh Syndrome Genetic Test is an important resource for families with a history of the disorder or for individuals presenting symptoms suggestive of Leigh syndrome. By confirming a diagnosis, the test can guide healthcare providers in developing a tailored management plan that may include nutritional support, respiratory care, and other interventions aimed at improving patient outcomes. DNA Labs UAE ensures a reliable and accurate testing process, providing crucial information for affected individuals and their families.
The SDHA Gene Leigh Syndrome Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at detecting mutations in the SDHA gene, which are associated with Leigh syndrome. Leigh syndrome is a severe neurological disorder that typically emerges in the first year of life, characterized by progressive loss of mental and movement abilities. Mutations in the SDHA gene disrupt the function of the mitochondrial complex II, leading to this condition.
The test involves collecting a DNA sample, usually through a blood draw or cheek swab, and analyzing it for specific genetic mutations in the SDHA gene. This genetic test is crucial for early diagnosis, allowing for timely intervention and management of the syndrome.
DNA Labs UAE provides this comprehensive genetic testing service at a cost of 4400 AED. The test is conducted in their state-of-the-art facilities, ensuring accurate and reliable results. By identifying the genetic basis of Leigh syndrome, this test plays a vital role in the clinical management of affected individuals, offering insights into treatment options and prognosis.
The ACAD9 Gene Leigh Syndrome and Mitochondrial Encephalopathy Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, aimed at identifying mutations in the ACAD9 gene, which are associated with Leigh syndrome and mitochondrial encephalopathy. Leigh syndrome, also known as subacute necrotizing encephalomyelopathy, is a severe neurological disorder that typically arises in the first year of life and is characterized by progressive loss of mental and movement abilities. Mitochondrial encephalopathy encompasses a range of disorders caused by dysfunction of the mitochondria, leading to neurological and muscular impairments.
The ACAD9 gene plays a crucial role in the function of mitochondria, the energy-producing structures within cells, making its mutations a critical factor in the development of these conditions. The test conducted at DNA Labs UAE involves analyzing the patient's DNA to detect any abnormalities in the ACAD9 gene that could lead to the development of Leigh syndrome or mitochondrial encephalopathy.
The cost of the ACAD9 Gene Leigh Syndrome and Mitochondrial Encephalopathy Genetic Test is 4400 AED. This investment covers the comprehensive analysis required to accurately identify the genetic markers associated with these conditions, providing essential information for diagnosis, treatment planning, and genetic counseling. Conducted in the state-of-the-art facilities of DNA Labs UAE, this test represents a crucial step for patients and families seeking answers to complex genetic disorders affecting the nervous system and muscular function.
The "SURF1 Gene Leigh Syndrome due to COX Deficiency Genetic Test" is a specialized diagnostic tool offered by DNA Labs UAE, aimed at detecting mutations in the SURF1 gene. These mutations are known to cause Leigh Syndrome, a severe neurological disorder that typically emerges in the first year of life. Leigh Syndrome associated with cytochrome c oxidase (COX) deficiency is specifically linked to the SURF1 gene alterations. This condition leads to progressive loss of mental and movement abilities, which can be fatal. The test, which costs 3200 AED, is crucial for early diagnosis and management of the syndrome. It involves analyzing the patient's DNA to identify any mutations in the SURF1 gene, providing vital information for treatment planning and genetic counseling for affected families. Conducted in the advanced facilities of DNA Labs UAE, this test is a key step towards personalized medicine for patients with Leigh Syndrome due to COX deficiency.
Leigh syndrome due to mitochondrial complex I deficiency is a severe neurological disorder that arises from genetic mutations affecting mitochondrial function, particularly the activity of complex I, a crucial enzyme in the mitochondrial respiratory chain. The MT-ND3 gene is one of the genes implicated in this condition. Mutations in the MT-ND3 gene can lead to impaired energy production in cells, resulting in the wide range of symptoms associated with Leigh syndrome, including developmental delay, muscle weakness, and breathing difficulties.
To diagnose this specific cause of Leigh syndrome, genetic testing is available at DNA Labs UAE. The test focuses on identifying mutations in the MT-ND3 gene that are known to contribute to mitochondrial complex I deficiency. This targeted genetic testing is crucial for confirming the diagnosis, understanding the disease's progression, and guiding treatment decisions.
The cost of the MT-ND3 gene Leigh syndrome due to mitochondrial complex I deficiency genetic test at DNA Labs UAE is 4400 AED. This investment covers the analysis of the MT-ND3 gene to detect mutations associated with the condition. By choosing this test, patients and their families can gain valuable insights into the genetic underpinnings of the disease, enabling more personalized and effective management strategies.
The MT-ND5 gene Leigh syndrome due to mitochondrial complex I deficiency is a genetic condition that affects the nervous system and other bodily functions. This condition is caused by mutations in the MT-ND5 gene, which is part of the mitochondrial DNA. These mutations lead to a deficiency in mitochondrial complex I, a crucial component of the mitochondrial respiratory chain responsible for energy production in cells. Symptoms of Leigh syndrome can include developmental delay, muscle weakness, breathing difficulties, and neurological problems.
To diagnose this specific form of Leigh syndrome, a genetic test is available at DNA Labs UAE. This test specifically looks for mutations in the MT-ND5 gene to confirm a diagnosis of Leigh syndrome due to mitochondrial complex I deficiency. The test is crucial for accurate diagnosis and management of the condition, allowing for tailored treatment plans and genetic counseling for affected families.
The cost of the MT-ND5 gene Leigh syndrome genetic test at DNA Labs UAE is 4400 AED. This investment covers the process of collecting a DNA sample, usually through a blood draw or cheek swab, and the detailed analysis conducted in the laboratory to detect any mutations in the MT-ND5 gene. Given the complexity of the test and the specialized technology used, the cost reflects the extensive resources required for accurate diagnosis.
For families and individuals facing symptoms indicative of Leigh syndrome, this genetic test provides a vital tool for understanding the underlying genetic cause and opens the door to targeted interventions and support services.
